LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule

17Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this study we aimed to identify small molecules with high affinity involved in the allosteric regulation of LVIS553, a MarR member from Lactobacillus brevis ATCC367. Using high throughput screening, novobiocin was found to specifically bind LVIS553 with a KD = 33.8 ± 2.9 μM consistent with a biologically relevant ligand. Structure guided site-directed mutagenesis identified Lys9 as a key residue in novobiocin recognition. The results found in vitro were correlated in vivo. An increased tolerance to the antibiotic was observed when LVIS553 and the downstream putative transport protein LVIS552 were either expressed in a low copy plasmid in L. brevis or as a single copy chromosomal insertion in Bacillus subtilis. We provide evidence that LVIS553 is involved in the specific regulation of a new mechanism of tolerance to novobiocin. © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Pagliai, F. A., Gardner, C. L., Pande, S. G., & Lorca, G. L. (2010). LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule. Journal of Biological Chemistry, 285(22), 16921–16930. https://doi.org/10.1074/jbc.M110.111138

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free